Streetbeat News

Products Services

HWH

HWH International Inc. (NASDAQ:HWH) provided an update on its business operations since becoming a public company. The update highlighted the stability and growth of its food and beverage division, particularly the Hapi Cafe brand, with outlets across Asia. HWH plans to expand its presence, launch membership sales with exclusive benefits, and seek collaborations for nutritious meal prep services. The Executive Chairman, Mr. Chan Heng Fai, expressed excitement for the future and upcoming promotions and events.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 2:11 pm

CSCO

TMUS

T-Mobile has partnered with Cisco to launch Connected Workplace, a new service that combines T-Mobile's 5G business internet with Cisco Meraki networking solutions and T-Mobile managed services. This service aims to provide businesses with an easier way to maintain secure connections for their branches and retail stores.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 2:05 pm

APEI

Graduate School USA (GSUSA) has been chosen for a pilot initiative aimed at training and upskilling financial managers across federal agencies. GSUSA provides over 200 courses designed to assist in the career development of 140,000 federal employees.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 2:05 pm

EQIX

Equinix, Inc. (NASDAQ:EQIX) has launched a fully managed private cloud service featuring NVIDIA DGX AI supercomputing infrastructure. This service is designed to help enterprises build and manage custom generative AI models. It includes NVIDIA's systems, networking, and AI Enterprise software platform, and is available in Equinix's IBX data centers globally. The service targets industries like biopharma, financial services, and retail, aiming to accelerate innovation and AI application development while ensuring data security and compliance.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 2:02 pm

MBRX

Moleculin Biotech, Inc. has released preliminary data from its Annamycin clinical trials, showing positive outcomes in treating acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases. The MB-106 AML trial has reached 67% recruitment with a CR rate of 40% and a CR/CRi rate of 47%. The first AML patient treated achieved a CR, and no CR/CRi patients have relapsed. The MB-107 STS Lung Mets trial reported a median overall survival of 11 months in heavily pre-treated subjects. All Annamycin subjects across multiple studies have shown no signs of cardiotoxicity. Moleculin anticipates multiple data readouts and a transition to pivotal Phase 2B/3 in 2024.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:58 pm

BTCS

BTCS Inc. (NASDAQ:BTCS), a blockchain technology company, issued a shareholder letter highlighting a successful 2023 with a 82% year-over-year increase in the fair market value of its crypto and cash to $26.7 million. The company anticipates over $6 million in net income for 2023, attributing this to the early adoption of new FASB accounting rules. BTCS plans to launch new Ethereum-based products and anticipates the introduction of an Ethereum ETF in 2024, although the timing is uncertain. The company also emphasized strategic cost-cutting and operational efficiency to navigate the challenging market.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:58 pm

CCL

CUK

Holland America Line, a division of Carnival Corp, set a new single-day sales record on January 16, 2024, surpassing the previous record by 18%. This achievement occurred during the cruise industry's high booking 'wave' season. A significant portion of the bookings were for Alaska cruises, and many reservations were made for 2025 or later. The record bookings coincide with Holland America's 'Time of Your Life' sale, offering various incentives to customers, including a free stateroom upgrade and onboard credit.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:56 pm

SILO

Silo Pharma has announced positive results from a preclinical study showing the effectiveness of SPC-14 in combating stress, helplessness, and anxiety related to luteinizing hormone (LH) in Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:55 pm

NFLX

Netflix Inc (NASDAQ:NFLX) stock is rising after reporting Q4 financial results. Revenue increased 12.5% YoY to $8.83 billion, surpassing estimates of $8.72 billion. Earnings per share were $2.11, missing the $2.21 estimate. Paid net adds were 13.12 million, with total subscribers at 260.28 million, a 12.8% increase YoY. Netflix plans to expand its ad-supported tier and expects Q1 revenue of $9.24 billion and earnings of $4.49 per share, with a full-year 2024 operating margin target of 24%. Keybanc and Wedbush raised their price targets, while Deutsche Bank downgraded the stock but increased its price target.

Portfolio Pulse from Adam Eckert

January 24, 2024 | 1:51 pm

CYTO

Altamira Therapeutics has filed a provisional patent application for its OligoPhore nanoparticles, which target various KRAS mutations in cancer treatment. Their polyKRASmut siRNA has demonstrated effectiveness in knocking down 65-91% of KRAS mutations across several cancer cell lines. This development is expected to bolster the intellectual property for Altamira's AM-401 nanoparticles aimed at treating KRAS-driven cancers.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:49 pm